Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Spectrum of clonal hematopoiesis in VEXAS syndrome.
Gutierrez-Rodrigues F, Kusne Y, Fernandez J, Lasho T, Shalhoub R, Ma X, Alessi H, Finke C, Koster MJ, Mangaonkar A, Warrington KJ, Begna K, Xie Z, Ombrello AK, Viswanatha D, Ferrada M, Wilson L, Go R, Kourelis T, Reichard K, Olteanu H, Darden I, Hironaka D, Alemu L, Kajigaya S, Rosenzweig S, Calado RT, Groarke EM, Kastner DL, Calvo KR, Wu CO, Grayson PC, Young NS, Beck DB, Patel BA, Patnaik MM. Gutierrez-Rodrigues F, et al. Among authors: olteanu h. Blood. 2023 Jul 20;142(3):244-259. doi: 10.1182/blood.2022018774. Blood. 2023. PMID: 37084382
Evaluation of multiple myeloma measurable residual disease by high sensitivity flow cytometry: An international harmonized approach for data analysis.
Soh KT, Came N, Otteson GE, Jevremovic D, Shi M, Olteanu H, Natoni A, Lagoo A, Theakston E, Óskarsson JÞ, Gorniak M, Grigoriadis G, Arroz M, Fletcher M, Lin P, Ludwig P, Tembhare P, Matuzeviciene R, Radzevicius M, Kay S, Chen W, Cabrita C, Wallace PK. Soh KT, et al. Among authors: olteanu h. Cytometry B Clin Cytom. 2022 Mar;102(2):88-106. doi: 10.1002/cyto.b.22053. Epub 2022 Jan 10. Cytometry B Clin Cytom. 2022. PMID: 35005838 Free PMC article.
Evaluation of CD43 expression in non-hematopoietic malignancies.
Batdorf BH, Kroft SH, Hosking PR, Harrington AM, Mackinnon AC, Olteanu H. Batdorf BH, et al. Among authors: olteanu h. Ann Diagn Pathol. 2017 Aug;29:23-27. doi: 10.1016/j.anndiagpath.2017.04.010. Epub 2017 Apr 26. Ann Diagn Pathol. 2017. PMID: 28807337
Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment Regimen.
Shah NN, Szabo A, Saba R, Strelec L, Kodali D, Vaughn JL, Esan O, Yang DT, Mato AR, Kanate AS, Olteanu H, Hamadani M, Fenske TS, Kenkre VP, Svoboda J, Cashen AF, Epperla N. Shah NN, et al. Among authors: olteanu h. Clin Lymphoma Myeloma Leuk. 2019 Feb;19(2):95-102. doi: 10.1016/j.clml.2018.11.010. Epub 2018 Nov 12. Clin Lymphoma Myeloma Leuk. 2019. PMID: 30581160
Immunophenotypes of Chronic Myelomonocytic Leukemia (CMML) Subtypes by Flow Cytometry:  A Comparison of CMML-1 vs CMML-2, Myeloproliferative vs Dysplastic, De Novo vs Therapy-Related, and CMML-Specific Cytogenetic Risk Subtypes.
Harrington AM, Schelling LA, Ordobazari A, Olteanu H, Hosking PR, Kroft SH. Harrington AM, et al. Among authors: olteanu h. Am J Clin Pathol. 2016 Aug;146(2):170-81. doi: 10.1093/ajcp/aqw084. Epub 2016 Jul 13. Am J Clin Pathol. 2016. PMID: 27413139
106 results